AVS Bio - Ownership and Business Overview

Life ScienceCompany

AVS Bio Ownership

Who owns AVS Bio?

AVS Bio is owned by Arlington Capital Partners. It was acquired on January 5, 2023.

Is AVS Bio PE-backed?

Yes. AVS Bio is owned by private equity investor Arlington Capital Partners.

AVS Bio Business Overview

Where is AVS Bio headquartered?

AVS Bio is headquartered in Norwich, Connecticut.

How many employees does AVS Bio have?

AVS Bio has 250 employees.

What sector is AVS Bio in?

AVS Bio is a life science company.

When was AVS Bio founded?

AVS Bio was founded in 1961.

Life Science M&A Summary in 2023

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2023. The largest life science acquisition in 2023 was Seagen - which was acquired by Pfizer for $43.0B.

Join Mergr to view all 192 acquisitions of life science companies in 2023, including 19 acquisitions by private equity firms, and 173 by strategics.

AVS Bio

Avian Vaccine Services LLC

1 Wisconsin Avenue,
Norwich, Connecticut 06360
United States,
(860) 889-1389
www.avsbio.com

AVS Bio is a provider of specific pathogen free eggs and adjacent laboratory products and services that support the development and manufacture of vaccines, therapeutics, and other biologics used for human and animal health. AVS Bio was founded in 1961 and is based in Norwich, Connecticut.


 Subscribe to unlock this and 202,409
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.